Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Assessing Efficacy, Safety, and Tolerability of EmSam in Bipolar Depression

NCT00535262 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT00535262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00535262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Assessing Efficacy, Safety, and Tolerability of EmSam in Bipolar Depression
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2007
Completion date
February 29, 2012
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression